Tralokinumab
Catalogue number:
HY-P99053-5mg
Supplier:
Size:
5 mg
Product is available in:
Applications:
COVID-19-immunoregulation
Target:
Apoptosis;Cadherin;Caspase;Interleukin Related
Alternative Names:
CAT354
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Tralokinumab (CAT354) is a humanized IgG4 monoclonal antibody that specifically binds to and neutralizes IL-13. Tralokinumab can be used in the research of diseases such as asthma, atopic dermatitis, and pulmonary fibrosis[1][2].